Chemicals and pharmaceuticals · CYDY

CytoDyn Inc.

8 filings mentioning 5 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

8filings we hold
5topics disclosed
Chemicals and pharmaceuticalsindustry
WAbased in

Across 8 filings we hold, CytoDyn Inc. has written down 5 of the topics we track. That places it 508 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

CYDY Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something CytoDyn Inc. has written into a filing. Not what they said. What applies once they have said it.

ISO/IEC 42001:202361
ISO 27001:202242
NIST AI Risk Management Framework (AI RMF 1.0)41
Colorado Artificial Intelligence Act (proposed SB 24-205)16
EU AI Act15
COSO Internal Control9
OECD Recommendation on Artificial Intelligence (2024 Update)8
Basel III International Banking Framework6
PCAOB AS 22014
MiFID II / MiFIR2

10 frameworks, 204 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Regulatory Reporting4
Internal Control3
Material Weakness2
Restatement1
Artificial Intelligence1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Regulatory Reporting42022-08-15
Internal Control32023-09-25
Material Weakness22022-08-05
Restatement12022-08-05
Artificial Intelligence12023-11-06

When it filed

Filings we hold, by year. Hover a bar for the count.

20
21
22
23

Recent filings

FiledFormItem
2023-11-068-KRegulation FD disclosure, Financial statements and exhibitsfiling
2023-09-258-KChange of accountant, Financial statements and exhibitsfiling
2022-08-1510-Kfiling
2022-08-058-KFinancial statements no longer reliablefiling
2022-04-198-KChange of accountant, Financial statements and exhibitsfiling
2021-07-3010-Kfiling
2020-08-1410-Kfiling
2020-01-0910-Qfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition